purine and pyrimidine metabolism in man x978-0-306-46843-8/1.pdfpurine and pyrimidine metabolism in...
TRANSCRIPT
PURINE AND PYRIMIDINEMETABOLISM IN MAN X
ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY
Editorial Board:
NATHAN BACK, State University of New York at Buffalo
IRUN R. COHEN, The Weizmann Institute of Science
DAVID KRITCHEVSKY, Wistar Institute
ABEL LAJTHA, N. S. Kline Institute for Psychiatric Research
RODOLFO PAOLETTI, University of Milan
Recent Volumes in this Series
Volume 476ANGIOGENESIS: From the Molecular to Integrative Pharmacology
Edited by Michael E. Maragoudakis
Volume 477CELLULAR PEPTIDASES IN IMMUNE FUNCTIONS AND DISEASES 2
Edited by Jürgen Langner and Siegfried Ansorge
Volume 478SHORT AND LONG TERM EFFECTS OF BREAST FEEDING ON CHILD HEALTH
Edited by Berthold Koletzko, Olle Hernell, and Kim Fleischer Michaelsen
Volume 479THE BIOLOGY AND PATHOLOGY OF INNATE IMMUNITY MECHANISMS
Edited by Yona Keisari and Itzhak Ofek
Volume 480BIOLOGY OF THE MAMMARY GLAND
Edited by Jan A. Mol and Roger A. Clegg
Volume 481ELASTIC FILAMENTS OF THE CELL
Edited by Henk L. Granzier and Gerald H. Pollack
Volume 482CHROMOGRANINS: Functional and Clinical Aspects
Edited by Karen B. Helle and Dominique Aunis
Volume 483TAURINE 4: Taurine and Excitable Tissues
Edited by Laura Della Corte, Ryan J. Huxtable, Giampietro Sgaragli,and Keith F. Tipton
Volume 484PHYLOGENETIC PERSPECTIVES ON THE VERTEBRATE IMMUNE SYSTEM
Edited by Gregory Beck, Manickam Sugumaran, and Edwin L. Cooper
Volume 485GENES AND PROTEINS UNDERLYING MICROBIAL URINARY TRACTVIRULENCE: Basic Aspects and Applications
Edited by Levente Emody, Tibor Pál, Jörg Hacker, and Gabriele Blum-Oehler
Volume 486PURINE AND PYRIMIDINE METABOLISM IN MAN X
Edited by Esther Zoref-Shani and Oded Sperling
A Continuation Order Plan is available for this series. A continuation order will bring delivery of each new volumeimmediately upon publication. Volumes are billed only upon actual shipment. For further information please contactthe publisher.
PURINE AND PYRIMIDINEMETABOLISM IN MAN X
Edited by
Esther Zoref-ShaniTel-Aviv UniversityTel -Aviv, Israel
and
Oded SperlingRabin Medical CenterPetah-Tikva, Israel andTel-Aviv UniversityTel-Aviv, Israel
KLUWER ACADEMIC PUBLISHERSNEW YORK, BOSTON, DORDRECHT, LONDON, MOSCOW
0-306- 46843-30-306-46515-9
©2002 Kluwer Academic PublishersNew York, Boston, Dordrecht, London, Moscow
All rights reserved
No part of this eBook may be reproduced or transmitted in any form or by any means, electronic,mechanical, recording, or otherwise, without written consent from the Publisher
Created in the United States of America
Visit Kluwer Online at: http://www.kluweronline.comand Kluwer's eBookstore at: http://www.ebooks.kluweronline.com
Print ISBN
eBook ISBN
PREFACE
This volume contains articles presented at the Xth InternationalSymposium on Purines and Pyrimidines in Man, held on May 14-19, 2000 inTel-Aviv, Israel. The first symposium in this series took place in Tel-Aviv in1973. Since then, the symposium has been held every three years in differentparts of the world, including Europe, USA and Japan. The participants, inthis series of symposia, are characterised by a wide interest in the variousaspects of purines and pyrimidines in man, which include biochemistry,genetics, pharmacology, physiology, clinics, etc. Presentations in thesymposia include clarification of metabolic pathways, characterisation ofenzyme structure and kinetics and discoveries of new inborn errors ofmetabolism and suggestions for new therapeutic approaches for these inbornerrors. In addition, development of new purine and pyrimidine derivativesfor the treatment of cancer and viral diseases, and many more subjects ofmutual interest were brought to the fore. With the development oftherapeutic means and of new research tools, we have witnessed changes inthe areas of interest. The interest in gout and uric acid urolithiasis haslessened, whereas molecular aspects, the role of purine and pyrimidinesubstances in neurotransmission and in purinergic signaling appear to gaingreater interest. The articles, included in this volume, contain new datapertaining to the various aspects detailed above.
We thank the Local Organising Committee, the International AdvisoryBoard and the Symposium Secretariat for their outstanding dedicationtowards making this symposium a success. We look forward to the XIth
symposium, to be held in Amsterdam, in 2003.
The Editors
v
CONTENTS
I. INBORN ERRORS OF PURINE METABOLISM
1. Purine and Pyrimidine Metabolism Between Millennia: What HasBeen Accomplished? What Has To Be Done? 1
G. Van den Berghe
2. Cell Type-Specific Differential Expression of Human5Phosphoribosylpyropshosphate Synthetase (PRPS) Genes
M.A. Becker, M. Ahmed
3. Mutations in the Hypoxanthine-GuaninePhosphoribosyltransferase Gene in Spanish HPRT DeficientFamilies 11
R.J. Torres, F.A. Mateos, J. Molano, B.S. Gathoff, J.P. O’Neill,R.M. Gundel, L. Trombley, J.G. Puig
4. The Spectrum of Hypoxanthine-Guanine Phosphoribosyltransferase(HPRT) Deficiency 15
J.G. Puig, R.J. Torres, F.A. Mateos, T. Ramos, A.S. Buno, J.Arcas
5. Deletion in the Hypoxanthine Phosphoribosyltransferase GeneCaused by ALU-ALU Recombination in Two JapanesePatients with Lesch-Nyhan Syndrome 23
M. Mizunuma, S. Fujimori, K. Kaneko, N. Kamatani
vii
viii Contents
6. Novel Genetic Mutations Responsible for the HPRT Deficiencyand the Clinical Phenotypes in Japanese
Y. Yamada, M. Nomura, H. Kitoh, N. Wakamatsu, N.Ogasawara
29
7. Adenoviruses Encoding HPRT Correct the BiochemicalAbnormalities Fully Only in HPRT-Deficient Human CellLines: Importance of Species Differences 35
T. Southgate, D. Bain, L.D. Fairbanks, A. Morelli, A. Larregina,H.A. Simmonds, M. Castro, P. Lowenstein
8. Biochemical and Immunological Abnormalities in PurineNucleoside Phosphorylase Deficient Mice
E. Arpaia, Y. Gu, I. Dalal, S. Kelly, M. Hershfield, C.M.Roifman, A. Cohen
41
9. Carrier Erythrocyte Entrapped Adenosine Deaminase Therapy inAdenosine Deaminase Deficiency 47
B.E. Bax, M.D. Bain, L.D. Fairbanks, H.A. Simmonds, A.D.Webster, R.A. Chalmers
10.ADA Activity and dATP levels in Erythrocytes after BoneMarrow Transplantation
L.D. Fairbanks, H.A. Simmonds, J.A. Duley, B. Gaspar, T.Flood, C. Steward
51
11. Adenosine Deaminase-Deficient Mice: Models for The Study ofLymphocyte Development and Adenosine Signaling 57
M.E. Aldrich, M.R. Blackburn, S.K. Datta, R.E. Kellems
12. Inhibition of Fetal Thymic Caspases Abrogates the Consequencesof Adenosine Deaminase Deficiency 65
C.J. Van De Wiele, S.W. Hooker, A.B. Laurent, J.G. VaughnM.R. Blackburn, R.E. Kellems, M.S. Hershfield, L.F.Thompson
13. Erythrocyte AMP Deaminase Deficiency in Japanese: ACompound Heterozygote Responsible for the CompleteDeficiency 71
Y. Yamada, H. Goto, N. Ogasawara
Contents ix
14. Effect of Uridine Administration to a Patient with75Adenylosuccinate Lyase Deficiency
C. Salerno, C. Crifo, P. Curatolo, F. Ciardo
15. Adenylosuccinate Lyase Deficiency: From the Clinics toMolecular Biology 79
S. Marie, V. Race, M.F. Vincent, G. Van den Berghe
16. Polymorphic Markrs in the XDH Gene as Diagnostic Tools forTyping Classical Xanthinuria 83
A. Lagziel, D. Levartovsky, O. Sperling, K. Ichida, H. Peretz
17. NAPDD Patients Exhibit Altered Electrophoretic Mobility ofCytosolic 5’-Nucleotidase
M. Trifilo, T. Page
18. Purines, Lactate and Myoinositol in CSF Might ReflectExcitotoxicity in Inherited Metabolic Disorders
A. Latini, L. Larovere, R. Dodelson de Kremer
19. Cerebrospinal Fluid Purines, Pyrimidines, Organic Acids andAmino Acids in Neonatal Citrullinaemia 97
87
91
L. Larovere, A. Latini, C. Depetris-Boldini, C.E. Coronel, R.Dodelson de Kremer
II. PURINE METABOLISM
20. Purine Nucleotide Catabolism in Rat Liver 103E. Marinello, R. Pagani, L. Arezzini, B. Porcelli, G. Cinci, L.
Terzuoli
21. Further Refinement on the Engineering of AdenosinePhosphorylase from Purine Nucleoside Phosphorylase 107
J.T. Maynes, R.G. Yuan, B.M. Phipps, S.A. Litster, K. Leung,F.F. Snyder
22. Human Guanine Deaminase: Cloning, Expression andCharacterization 111
F.F. Snyder, R.G. Yuan, J.C. Bin, K.L. Carter, D.J. McKay
x Contents
23. The Human NUTD Family of Nucleotide Hydrolases 115A.G. McLennan, J.L. Cartwright, L. Gasmi
24. Inhibitors of NTPDase: Key Players in the Metabolism ofExtracellular Purines 119
F.P. Gendron, E. Halbfinger, B. Fischer, A.R. Beaudoin
25. Apoptosis-Inducing Cleavage of Caspases by Trimidox, anInhibitor of Ribonucleotide Reductase 125
M.Fritzer-Szekeres, C. Luxbacher, Z. Horvath, M. Grusch,G. Krupitza, H.L. Elford, T. Szekeres
III. GOUT AND HYPERURICEMIA
26. Increased Visceral Fat Accumulation in Patients with PrimaryGout 131
S. Takahashi, T. Yamamoto, Z. Tsutsumi, Y. Moriwaki, T. Hada
27. Serum Uric Acid Levels and Microalbuminuria in MildHypersensitive Patients 135
R.J. Torres, M.A. Martinez, T. Sancho, A.. Moreno, R. Cabrera,A. Aguirre, A. Torre, A. Nevado, J.G. Puig
IV. PURINES IN CARDIOLOGY
28. Guanosine-5’-Triphosphate Increases in Red Blood Cells of HeartTransplant Recipients Treated with Mycophenolate Mofetil 139
A. Griesmacher, G. Weigel, G. Seebacher, M.M. Müller
29. Adenine Incorporation in Endothelial Cells 145K.K. Kalsi, M. Zych, E. Slominska, Z. Kochan, M.H. Yacoub,
R.T. Smolenski,
30. TNF-α Reduces the Activity of Ecto-5'-Nucleotidase in HumanEndothelial Cells 149
K.K. Kalsi, C Lawson, A. McCormack, Z. Kochan, M.H.Yacoub, R.T. Smolenski
Contents xi
31. Influence of Age and Heat Stress on Cardiac Function andNucleotide Levels
C.C. Gray, R.T. Smolenski, M. Amrani, G.L. Taylor, M.H.Yacoub
153
32. The Role of 5’-Deoxy-5’-Methylthioadenosine Phosphorylase inCardiac Adenosine Breakdown and Adenine Production 159
E M. Slominska, K.K. Kalsi, M.H. Yacoub and K.T. Smolenski
33. The Effect of Adenosine Metabolism Inhibition and NucleotidePrecursor Supply on Adenosine Production in Human HeartEndothelial Cells 163
R.T. Smolenski, K.K. Kalsi, C.C. Gray, M. Zych, Z. Kochan,M.H. Yacoub
34. Enhanced Endogenous Adenosine Production and Protection ofthe Heart after Transplantation 167
R.T. Smolenski, O. Raisky, K.K. Kalsi, H. Abunasra, J.Jayakumar, K. Suzuki, M.H. Yacoub
35. Role of Bovine Hemoglobin Enriched Cardioplegia inMyocardial Preservation 171
E. Marinello, A. Tabucchi, F. Miraldi, A. Barretta, F. Rosi, F.Carlucci
V. RENAL HANDLING OF PURINES
36. Identification of the Potential Sensitive Urate/PAH Transporterfrom LLC-PK1 Kidney Epithelial Cells 175
F. Spitzenberger, J. Graessler, H-E. Schroeder
37. Genomic Structure of Galectin-9 Gene. Mutation Analysis of aPutative Human Urate Channel/Transporter 179
J. Graessler, F. Spitzenberger, A. Graessler B. Parpart, E.Kuhlisch, S. Kopprasch, H-E. Schroeder
38. Effect of Losartan and Furosemide on the Urinary Excretion ofOxypurinol and Uric Acid 185
T. Yamamoto, Y. Moriwaki, S. Takahashi, Z. Tsutsumi, T. Hada
xii Contents
VI. PURINERGIC SIGNALLING
39. P2y and P2x Purinoceptors Are Respectively Implicated inEndothelium-Dependent Relaxation and EndotheliumIndependent Contraction In Human Corpus Cavernosum 189
F. Staerman, M. Shalev, A. Legrand, B. Label, B. Saïag
40. ATP-Triggered Calcium Signals in Human Neutrophils 197C. Crifo, E. Capuozzo, J. Ovadi, C. Salerno
41. The Role of A1/A3 Adenosine Receptor Activation in Reductionof Cardiomyocyte Injury Caused by Hypoxic Stress and inInduction of Apoptosis in Rat Cardiomyocyte Cultures 201
A. Shainberg, N. Safran, N. Balas, T. Zinman, A. Isaac, K.Schwab, B. Akabayov, V. Shneyvays
42. Blockade of A1 Receptors by Caffeine Induces C-fos, Zif-268 andarc Expression in the Striatum through DifferentInteractions with the Dopamine System 207
D. Dassesse, J.-M.. Vanderwinden, I. Golberg, J.-J.Vanderhaeghen, S.N. Schiffmann
43. Role of KATP Channels in the Induction of Ischemic Toleranceby the ‘Adenosine Mechanism’ in Neuronal Cultures 217
A. Reshef, O. Sperling, E. Zoref-Shani
44. Adenosine-Induced Caspase Activity in N1E-115 Cells 223S.M. Schrier, A.P. Ijzerman, G.J. Mulder, J.F. Nagelkerke
45. Effect of Adenosine Receptor Agonists and Antagonists onTransport of Adenosine in Bovine Heart MicrovascularEndothelial Cells 227
J. Barankiewicz
VII. INBORN ERRORS OF PYRIMIDINE METABOLISM
46. Defects of Pyrimidine Degradation: Clinical, Molecular andDiagnostic Aspects
A.H. van Gennip, A.B.P. van Kuilenburg233
Contents
47. Confirmation of the Enzyme Defect in the First Case of
A.B.P. van Kuilenburg H. van Lenthe, G. Göhlich-Ratmann, B.
48. Dihydropyrimidine Dehydrogenase (DPD) Deficiency: Novel
A.B.P. van Kuilenburg, J. Haasjes, R. Meinsma, H.R. Waterham,
49. Dihydropyrimidine Dehydrogenase Deficiency and 5-Fluorouracil Associated Toxicity 251
A.B.P. van Kuilenburg, J. Haasjes, H. Van Lenthe, L.Zoetekouw, H.R. Waterham, P. Vreken, A.H. van Gennip
50. Isoforms of Human CTP Synthetase 257
A.H. van Gennip
β-Ureidopropionase Deficiency 243
Assmann, G.F. Hoffmann, C. Brautigam, A.H. van Gennip
Mutations in the DPD Gene 247
P. Vreken, A.H. van Gennip
A.B.P. van Kuilenburg, R. Meinsma, P. Vreken, H.R. Waterham,
VIII. PYRIMIDINE METABOLISM
51. Polyclonal Antibodies Against the Ultrafast MultisubstrateDeoxy-ribonucleoside Kinase from Drosophila Melanogaster
W. Knecht, B. Munch-Petersen, J. Piskur
52. Inhibition and Localizaton of Human and Rat DihydroorotateDehydrogenase
263
267W. Knecht, M. Loffler
IX. ONCOLOGY AND CHEMOTHERAPY
53. 6-Mercaptopurine: Efficacy and Bone Marrow Toxicity inChildhood Acute Lymphoblastic Leukemia
R.A. De Abreu, L.H.J. Lambooy, K. Ahment, C. Brouwer, J.JKeizer-Garritsen, J.P.M. Bokkerink, F.J.M. Trijbels
54. Recovery of SK-N-BE(2)C Cells from Treatment withCyclopentenyl Cytosine
271
277J. Bierau, A.H. van Gennip, A.B.P. van Kuilenburg
xiii
xiv Contents
55. Effect of Phosphorylation on Deoxycytidine Kinase Activity 281T. Spasokoukotskaja, Z. Csapo, M. Sasvari-Szekely, S. Virga, I.
Talianidis, S. Eriksson, M. Staub
56. The Role of Deoxycytidine Kinase in Gemcitabine Cytotoxicity 287C.L. van der Wilt, J.R. Kroep, A.M. Bergman, W.J.P. Loves, E.
Alvarez, I. Talianidis, C.J. van Groeningen, H.M. Pinedo, G.J. Peters
57. Thymidine Phosphorylase in Angiogenesis and Drug Resistance 291G.J. Peters, M. De Bruin, M. Fukushima, B. Van Triest, K.
Hoekman, H. M. Pinedo, S. P. Ackland
58. Secretion of Thymidine by Hybridoma Cells 295B. Spilsberg, F. Rise, D. Petersen, J. Nissen-Meyer
59. Thymidylate Synthase Inhibition Induces P53 Dependent andIndependent Cell Death 303
H.H.J. Backus, D. Wouters, C.L. van der Wilt, C.M. Kuiper, C.J.van Groeningen, H.M. Pinedo, G.J. Peters
60. 2-Chlorodeoxyadenosine (2-CDA) Does Not Change theExpression of FAS Antigen on Chronic LymphocyticLeukaemia Cells 307
J. Gora-Tybor, E. Lech-Maranda, J.Z. Blonski, T. Robak
61. Cyclopentenyl Cytosine Increases the Phosphorylation andIncorporation into DNA of Arabinofuranosyl Cytosine in aMyeloid Leukemic Cell-Line 311
A.C. Verschuur, A.H. van Gennip, R. Leen, P.A. Voute, A.B.P.van Kuilenburg,
62. Cyclopentenyl Cytosine Induces Apoptosis and SecondaryNecrosis in a T-Lymphoblastic Leukemic Cell-Line
A.C. Verschuur, A.H. van Gennip, J. Brinkman, P.A. Voûte,A.B.P. van Kuilenburg,
319
63. Thiopurine Methyltransferase: Activity and Genotyping inPatients with Acute Lymphoblastic Leukemia 327
C. Brouwer, J.J. Keizer-Garritsen, L.H.J. Lambooy, K. Ament,P.G.J.H. Ter Riet, R.A. De Abreu, J.P.M. Bökkerink,E.R. Van Wering, A. Van Der Does-Van Den Berg, A.J.P.Veerman, J.P.M.F. Trijbels
Contents xv
64. Hyperthermy Increase the Phosphorylation and Decrease theIncorporation of Nucleosides into DNA
G. Keszler, Z. Csapo, T. Spasokoutskaja, M. Sasvari-Szekely,S. Virga, A. Demeter, S. Eriksson, M. Staub
65. Purine Nucleotide Metabolism in Chronic LymphocyticLeukemia Lymphocytes
E. Marinello, F. Carlucci, F. Rosi, A. Tabucchi
66. Inhibition of DNA Methylation by 5-Aza-2’-DeoxycytidineCorrelates with Induction of K562 Cells Differentiation
K. Fabianowska-Majewska, D. Wyczechowska, M. Czyz
67. Evidence of Inhibition of DNA Methylation by FludarabineD. Wyczechowska, M. Czyz, K. Fabianowska-Majewska
68. The Cytotoxic Effect of Purine Riboside on Cos-7 CellsK. Tkacz, M. Cioroch, A.C. Skladanowski, W. Makarewicz
69. Methylated and Non Methylated Thiopurine Nucleotide Ratio(Me6-Mpn/6-Tgn): Usefulness In The Monitoring OfAzathioprine Therapy?
R. Boulieu, T. Dervieux, I. Gallant, M. Sauviat, M. Bertocchi,J.F. Mornex,
X. METHODS
70. Organ Preservation During Experimental Liver TransplantationE. Marinello, A. Tabucchi, F. Rosi, G. Gerunda, R. Merenda, R.
Ballarin, D. Neri, F. Carlucci
333
339
343
349
355
361
369
71. Extraction and Purification of Ecto-5'-Nucleotidase from HumanLymphocytes 373
E. Marinello, F. Rosi, A. Tabucchi, F. Carlucci, G. Cinci, M.Coli, A. Floridi, C. Fini
72. HPLC/ESI Tandem-MS of Liquid Urine or Urine Soaked FilterPaper Strips for the Detection of Thymine-Uraciluria andDihydropyrimidinuria 377
A.H. Van Gennip, H. Van Lenthe, T. Ito, A.H. Bootsma, A.C.Van Cruchten, Y. Wada, A.B.P. Van Kuilenburg
xvi Contents
73. Screening for Purine and Pyrimidine Disorders using Dried UrineSpots
L.D. Fairbanks, E. Escuredo, J.A. Duley, H.A. Simmonds
Determination of Methylated Purine Bases in Urine from HealthySubjects 389
E. Marinello, M.C. Di Pietro, R. Leoncini, G. Liso, R. Guerranti,G. Cinci, D. Vannoni
Decrease in Urinary Uric Acid Concentrations after UrineStorage 393
Y. Moriwaki, T. Yamamoto, S. Takahashi, J-I. Yamakita, Z.Tsutsumi, T. Hada
Mass Spectrometry for Analysis of Purine and PyrimidineCompounds
K. Lemr, T. Adam, P. Frycak, D. Friedecky399
405
415
383
74.
75.
76.
Author Index
Subject Index